NCT01853644 2021-10-12
TIVO
Northwestern University
Phase 2 Completed
Clinical Trials
5 trialsNCT01835223 2020-10-28
Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase 1/2 Completed
NCT01782313 2019-09-09
A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
Northwestern University
Phase 2 Completed
NCT01846871 2019-01-08
Tivozanib for Recurrent Glioblastoma
Massachusetts General Hospital
Phase 2 Completed
NCT01058655 2017-04-13
RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer
Dana-Farber Cancer Institute
Phase 1/2 Completed